Jynarque Kit
Product Images NDC 59148-087

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Jynarque (NDC 59148-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Carton)

Jynarque (tolvaptan) tablets 15 mg packaging label for a kit containing 56 tablets arranged in 4 child-resistant weekly packs of 14 tablets each. The label shows dosing strengths of 15 mg per tablet and includes storage instructions and manufacturer details from Otsuka America Pharmaceutical, Inc.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Carton)

Jynarque 15 mg tablets packaging label for a kit containing 30 tablets of tolvaptan. The carton displays the brand and generic names, strength, tablet count, and instructs to dispense the enclosed medication guide. Distributed by Otsuka America Pharmaceutical, Inc., and manufactured by Otsuka Pharmaceutical Co., Ltd., Japan. Storage instructions and dosage information are included.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Jynarque (tolvaptan) tablets kit by Otsuka America Pharmaceutical, Inc. The label shows strengths of 15 mg and 30 mg per tablet. The kit contains 56 tablets in monthly cartons with four child-resistant weekly packs, each pack including 7 tablets of 30 mg and 7 tablets of 15 mg. The label features dosage information, storage instructions, and the manufacturer information, along with a barcode and branding elements.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Carton)

Carton label for Jynarque 30 mg tablets (tolvaptan) kit by Otsuka America Pharmaceutical, Inc. The label shows a 30-tablet count with instructions to dispense the enclosed medication guide. It features the proprietary name, generic name, strength, and product information including storage instructions and manufacturer details. Barcodes and serialization data are also visible on the packaging.*

FDA Label Image

Principal Display Panel (Kit Carton)

Jynarque (tolvaptan) tablets kit packaging label showing 45 mg and 15 mg per tablet strengths. The label states the kit contains 56 tablets in 4 child-resistant weekly packs, each with 14 tablets (7 tablets of 45 mg and 7 tablets of 15 mg). Distributed by Otsuka America Pharmaceutical, Inc., the label includes storage instructions and a barcode, with prominent brand and active ingredient display.*

FDA Label Image

Principal Display Panel (Kit Carton)

Jynarque (tolvaptan) tablets kit packaging label showing 60 mg and 30 mg tablet strengths. The label indicates a monthly carton with 56 tablets in four child-resistant weekly packs, each weekly pack containing a blister card with 14 tablets (7 x 60 mg and 7 x 30 mg). The labeler is Otsuka America Pharmaceutical, Inc. It includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (Kit Carton)

Jynarque (tolvaptan) tablets kit carton showing two tablet strengths: 90 mg and 30 mg per tablet. The kit contains 56 tablets, arranged as 4 child-resistant weekly packs, each pack including a blister card with 14 tablets (7 tablets of 90 mg and 7 tablets of 30 mg). The labeler is Otsuka America Pharmaceutical, Inc., with manufacturing by Otsuka Pharmaceutical Co., Ltd., Japan. Storage instructions and dispensing guidance are partially visible.*

FDA Label Image

Chemical Structure (Jynarque Chem Structure)

Chemical structure of tolvaptan, the active ingredient in Jynarque. The diagram depicts the molecular framework, including rings and key functional groups such as hydroxyl, chlorine, and amide groups, characteristic of tolvaptan's chemical design.*

FDA Label Image

Principal Display Panel (15-15 mg Sleeve)

Packaging label for Jynarque tablets kit by Otsuka America Pharmaceutical, Inc., containing 14 tablets with strengths of 15 mg per tablet. The weekly pack includes 1 blister card with 14 tablets (14 x 15 mg). The label shows instructions for opening and emphasizes dispensing the enclosed medication guide with each pack. The NDC is 59148-079-07.*

FDA Label Image

Principal Display Panel (15 mg Tablet LBL)

Jynarque 15 mg tablets packaging label showing tolvaptan as the active ingredient. The label indicates a quantity of 30 tablets in a bottle, with the product marketed and distributed by Otsuka America Pharmaceutical, Inc. The label includes storage instructions and dosage information referencing the prescribing information.*

FDA Label Image

Principal Display Panel (30-15 mg Sleeve)

Jynarque tolvaptan tablets kit packaging label showing a weekly pack containing 14 tablets with 7 tablets of 30 mg and 7 tablets of 15 mg strengths. The label includes instructions on opening the blister card, the NDC number 59148-080-07, and indicates it is a prescription drug by Otsuka America Pharmaceutical, Inc.*

FDA Label Image

Principal Display Panel (30 mg Tablet LBL)

Jynarque 30 mg tablets label showing it contains tolvaptan as the active ingredient. The package includes 30 tablets and is labeled for prescription use only. Instructions state to dispense the enclosed medication guide. Manufactured by Otsuka Pharmaceutical Co., Ltd. and distributed by Otsuka America Pharmaceutical, Inc. Storage instructions and recommended dosage information reference the prescribing information.*

FDA Label Image

Principal Display Panel (45-15 mg Sleeve)

Jynarque (tolvaptan) tablets kit packaging label showing a weekly pack with 14 tablets, including 7 tablets of 45 mg and 7 tablets of 15 mg strength. The label features instructions to open the blister card, dosage strengths, and the labeler Otsuka America Pharmaceutical, Inc., along with NDC 59148-087-07.*

FDA Label Image

Principal Display Panel (60-30 mg Sleeve)

Jynarque (tolvaptan) tablets 60 mg and 30 mg, weekly pack kit containing 14 tablets (7 tablets of 60 mg and 7 tablets of 30 mg) in a blister card. Packaging includes instructions to press a button to open and pull out foil packages. Labeler is Otsuka America Pharmaceutical, Inc. The packaging displays the NDC 59148-088-07 and Rx only indication.*

FDA Label Image

Principal Display Panel (90-30 mg Sleeve)

Packaging label for Jynarque (tolvaptan) tablets kit by Otsuka America Pharmaceutical, Inc. The kit contains 14 tablets in a weekly pack with 7 tablets of 90 mg and 7 tablets of 30 mg strength. The label includes instructions to open the blister pack and a note to dispense the enclosed medication guide to each patient. The NDC is 59148-089-07.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.